Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of prognostic hub genes and therapeutic targets for selenium deficiency in chicks model through transcriptome profiling. | Sci Rep | 2023 | 37248251 | PubTator, text mining | PubMed |
| Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion. | Nat Commun | 2023 | 37225706 | PubTator, text mining | PubMed |
| Asparagine synthetase and G-protein coupled estrogen receptor are critical responders to nutrient supply in KRAS mutant colorectal cancer. | bioRxiv | 2023 | 37205388 | PubTator, text mining | PubMed |
| Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics. | Cancer Metastasis Rev | 2023 | 37204562 | PubTator, text mining | PubMed |
| Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry. | Oncologist | 2023 | 37196060 | PubTator, text mining | PubMed |
| Reviewing the Prospective Pharmacological Potential of Isothiocyanates in Fight against Female-Specific Cancers. | Cancers (Basel) | 2023 | 37190316 | PubTator, text mining | PubMed |
| TGF-β as Predictive Marker and Pharmacological Target in Lung Cancer Approach. | Cancers (Basel) | 2023 | 37190223 | PubTator, text mining | PubMed |
| Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance. | Cancers (Basel) | 2023 | 37190191 | PubTator, text mining | PubMed |
| Transcriptional Profiling of a Patient-Matched Cohort of Glioblastoma (IDH-Wildtype) for Therapeutic Target and Repurposing Drug Identification. | Biomedicines | 2023 | 37189838 | PubTator, text mining | PubMed |
| The SHDRA syndrome-associated gene TMEM260 encodes a protein-specific O-mannosyltransferase. | Proc Natl Acad Sci U S A | 2023 | 37186866 | Swiss-Prot, curated | PubMed |
| The miR-141/200c-STAT4 Axis Contributes to Leukemogenesis by Enhancing Cell Proliferation in T-PLL. | Cancers (Basel) | 2023 | 37173993 | PubTator, text mining | PubMed |
| Integration of ATAC-Seq and RNA-Seq reveals FOSL2 drives human liver progenitor-like cell aging by regulating inflammatory factors. | BMC Genomics | 2023 | 37173651 | PubTator, text mining | PubMed |
| Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going? | Curr Treat Options Oncol | 2023 | 37145382 | PubTator, text mining | PubMed |
| Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer. | Front Endocrinol (Lausanne) | 2023 | 37143720 | PubTator, text mining | PubMed |
| A network map of macrophage-stimulating protein (MSP) signaling. | J Cell Commun Signal | 2023 | 37142846 | PubTator, text mining | PubMed |
| Exploring the anti-cancer potential of dietary phytochemicals for the patients with breast cancer: A comprehensive review. | Cancer Med | 2023 | 37132286 | PubTator, text mining | PubMed |
| Epigenetic modulation and prostate cancer: Paving the way for NK cell anti-tumor immunity. | Front Immunol | 2023 | 37090711 | PubTator, text mining | PubMed |
| Nanobody inhibitors of Plexin-B1 identify allostery in plexin-semaphorin interactions and signaling. | J Biol Chem | 2023 | 37088134 | PubTator, text mining | PubMed |
| The Clinical Significance of CD163+ Tumor-Associated Macrophages (TAMs) in Laryngeal Squamous Cell Carcinoma. | Cureus | 2023 | 37082492 | PubTator, text mining | PubMed |
| MST1R as a potential new target antigen of chimeric antigen receptor T cells to treat solid tumors. | Korean J Physiol Pharmacol | 2023 | 37078298 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers?page=8